| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/04/2009 | WO2009069808A1 Epha4 polypeptide having novel activity and use thereof |
| 06/04/2009 | WO2009069546A1 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 06/04/2009 | WO2009069381A1 Transformant transfected with flavin adenine dinucleotide-binding glucose dehydrogenase gene and method for producing flavin adenine dinucleotide-binding glucose dehydrogenase using the same |
| 06/04/2009 | WO2009069355A1 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 06/04/2009 | WO2009069310A1 Method for stabilization of aqueous solution containing phenothiazine-type oxidative color-developing agent and protease |
| 06/04/2009 | WO2009069309A1 Method for stabilizing phenothiazine oxidation color former-containing aqueous solution |
| 06/04/2009 | WO2009069152A2 Genetic variants on chr hq and 6q as markers for prostate and colorectal cancer predisposition |
| 06/04/2009 | WO2009068998A1 A mammalian cell-based screening assay to identify inhibitors of alphaviruses |
| 06/04/2009 | WO2009068883A1 Genetic tests to genotype the hla-drb1 gene in scarring |
| 06/04/2009 | WO2009068753A1 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 06/04/2009 | WO2009068677A1 Novel tissue protective erythropoietin receptor (nepor) and methods of use |
| 06/04/2009 | WO2009068655A1 A method to assess prognosis and to predict therapeutic success in gynecologic cancer |
| 06/04/2009 | WO2009068621A1 Method for classifying cancer patients as responder or non-responder to immunotherapy |
| 06/04/2009 | WO2009068604A1 Marker assisted directed evolution |
| 06/04/2009 | WO2009068591A2 Biomarkers for the onset of neurodegenerative diseases |
| 06/04/2009 | WO2009068554A1 Synthase inhibitor screening method |
| 06/04/2009 | WO2009068481A1 Novel bank1 splice variant |
| 06/04/2009 | WO2009068466A1 Magnetic recording medium |
| 06/04/2009 | WO2009068445A1 The present invention relates to methods for prediction of the therapeutic success of breast cancer therapy |
| 06/04/2009 | WO2009068430A1 Method for therapy prediction in tumors having irregularities in the expression of at least one vegf ligand and/or at least one erbb-receptor |
| 06/04/2009 | WO2009068423A2 Method for predicting therapy responsiveness in basal like tumors |
| 06/04/2009 | WO2009068409A1 A method to assess prognosis and to predict therapeutic response to endocrine treatment |
| 06/04/2009 | WO2009068308A2 New malonate decarboxylases for industrial applications |
| 06/04/2009 | WO2009068305A1 Steganographic embedding of information in coding genes |
| 06/04/2009 | WO2009068269A1 Screening method for agents suitable for therapy of alzheimer's disease |
| 06/04/2009 | WO2009068211A1 Method for determining the presence and/or absence of a plurality of target sequences in a biological sample |
| 06/04/2009 | WO2009067903A1 Method for detecting the expression of cyclin b2 gene by real-time quantitative pcr |
| 06/04/2009 | WO2009067812A1 Pd-1 modulation and uses thereof |
| 06/04/2009 | WO2009067790A1 STIMULATION OF HYPOXIA INDUCIBLE FACTOR -1 ALPHA (HIF-1α) FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE (CDAD), FOR INTESTINAL MOTILITY AND FOR DETECTING INFECTION |
| 06/04/2009 | WO2009067784A1 Nucleotide sequence encoding artemisinic aldehyde double bond reductase, artemisinic aldehyde double bond reductase and uses thereof |
| 06/04/2009 | WO2009067744A1 Thermal cycling device |
| 06/04/2009 | WO2009067743A1 Enzymes for amplification and copying bisulphite modified nucleic acids |
| 06/04/2009 | WO2009052484A3 Predicting responsiveness to cancer therapeutics |
| 06/04/2009 | WO2009047756A3 Methods and kits for diagnosing lung cancer |
| 06/04/2009 | WO2009044154A3 Transcription factor decoys, compositions and methods |
| 06/04/2009 | WO2009036514A3 Method of amplifying nucleic acid |
| 06/04/2009 | WO2009033095A3 Humanized pai-1 antibodies |
| 06/04/2009 | WO2009031105A3 Non-homogeneous modification of liquids |
| 06/04/2009 | WO2009009432A3 Recurrent gene fusions in prostate cancer |
| 06/04/2009 | WO2009007685A3 Method |
| 06/04/2009 | WO2008155661A3 Methods of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer |
| 06/04/2009 | WO2008149237A3 Method for methylation analysis |
| 06/04/2009 | WO2008071385A3 Use of acetals for the isolation of nucleic acids |
| 06/04/2009 | WO2008036347A3 Methods and apparatus for stimulating and managing power from microbial fuel cells |
| 06/04/2009 | WO2006110358A3 Methods and compositions for introducing biopolymers into cells |
| 06/04/2009 | WO2006108087A3 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 06/04/2009 | WO2006105409A3 Multiplex assay systems |
| 06/04/2009 | WO2006105252A3 Diagnosis of chronic pulmonary obstructive disease and monitoring of therapy using gene expression analysis of peripheral blood cells |
| 06/04/2009 | WO2006099259A3 Novel missense mutations and single nucleotide polymorphisms in the rabphillin-3a-like gene and uses thereof |
| 06/04/2009 | WO2006096427A3 Association between markers in the leptin gene and carcass traits in commercial feedlot steer and heifers |
| 06/04/2009 | WO2006089163A3 Methods and probes for detecting esophageal cancer |
| 06/04/2009 | WO2006074061A3 Methods for identifying risk of low bmd and treatments thereof |
| 06/04/2009 | WO2006012586A3 Modulation of fiaf and the gastrointestinal microbiota |
| 06/04/2009 | WO2005118875A3 Diagnosing or predicting the course of breast cancer |
| 06/04/2009 | WO2005017099A3 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 06/04/2009 | WO2001085325A3 Parallel chemical reactor |
| 06/04/2009 | WO2001079222A3 Haplotypes of the mc4r gene |
| 06/04/2009 | WO2001055301A3 Nucleic acids, proteins, and antibodies |
| 06/04/2009 | US20090144863 Expression Enhancing Intron Sequences |
| 06/04/2009 | US20090144860 Genes involved in asymmetric cell division |
| 06/04/2009 | US20090144857 Receptors for hypersensitive response elicitors and uses thereof |
| 06/04/2009 | US20090144855 Compositions and Methods Comprising Stinging Capsules/Cells For Delivering a Biologically Active Agent Into a Plant Cell |
| 06/04/2009 | US20090144851 Plant amino acid biosynthetic enzymes |
| 06/04/2009 | US20090144846 Tomato variety picus |
| 06/04/2009 | US20090144841 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications |
| 06/04/2009 | US20090143995 System and Method for Management and Evaluation of Genotyping Data |
| 06/04/2009 | US20090143993 Method of Diagnosing the Presence and/or Severity of a Hepatic Pathology in an Individual and/or of Monitoring the Effectiveness of a Treatment for one such Pathology |
| 06/04/2009 | US20090143754 Personal Care Products with Visual Indicator of Vaginitis |
| 06/04/2009 | US20090143487 Enhanced stability of proteins immobilized on nanoparticles |
| 06/04/2009 | US20090143467 Anticancer agents based on regulation of protein prenylation |
| 06/04/2009 | US20090143451 Compounds that increase telomerase reverse transcriptase (tert) expression and methods for using the same |
| 06/04/2009 | US20090143450 Method for treating central pain syndrom or for inducing centrally generated pain in an animal model |
| 06/04/2009 | US20090143327 General composition framework for ligand-controlled regulatory systems |
| 06/04/2009 | US20090143320 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 06/04/2009 | US20090143308 Yeast membrane protein expression system and its application in drug screening |
| 06/04/2009 | US20090143298 Broad-Spectrum Delta-Endotoxins and Method and Kit for Detecting Same and for Detecting Polynucleotides Encoding Same |
| 06/04/2009 | US20090143297 Modulators of antiestrogen pharmacology |
| 06/04/2009 | US20090143293 Peptide inhibitors of protein kinase C gamma for pain management |
| 06/04/2009 | US20090143290 Tumor-inhibiting protein and the use thereof |
| 06/04/2009 | US20090143285 Target protein and target gene for drug discovery and screening method |
| 06/04/2009 | US20090143279 Methods and compositions for treating metabolic disorders |
| 06/04/2009 | US20090143251 Apparatus for producing probe carrier |
| 06/04/2009 | US20090143249 Bioarray chip reaction apparatus and its manufacture |
| 06/04/2009 | US20090143244 System and apparatus for sequential processing of analytes |
| 06/04/2009 | US20090143242 Alien sequences |
| 06/04/2009 | US20090143241 Antibacterial and plasmid elimination agents |
| 06/04/2009 | US20090143239 Fluorescence based biosensor |
| 06/04/2009 | US20090143237 Methods, kits and compositions pertaining to fluorescence quenching using pna probes |
| 06/04/2009 | US20090143236 Method of detecting cancer cell acquiring drug-resistance |
| 06/04/2009 | US20090143232 Method for synthesising templated molecules |
| 06/04/2009 | US20090142829 Recombinant Constructs And Their Use In Reducing Gene Expression |
| 06/04/2009 | US20090142826 Diffraction-Based Diagnostic Devices |
| 06/04/2009 | US20090142821 Polymorphic monooxygenase comprising mutation in heme domain of a secondary structural element and enhanced heat stability; improved peroxide-driven hydroxylation |
| 06/04/2009 | US20090142810 use of 2'-terminator nucleotides to effect chain termination; kits; incubating a template nucleic acid with a nucleotide incorporating biocatalyst, and a 2'-terminator nucleotide |
| 06/04/2009 | US20090142801 butyrophilin-like nucleic acids; for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen |
| 06/04/2009 | US20090142800 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/04/2009 | US20090142797 Blood diluent and method of use thereof |
| 06/04/2009 | US20090142796 Detection of Inducible Resistance to Macrolide-Lincosamide-Streptogramin b |
| 06/04/2009 | US20090142795 Apparatus for monitoring migratory activity of semen components; in vitro fertilization; animal husbandry; veterinary medicine |
| 06/04/2009 | US20090142794 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |